ATAI logo

ATAI Atai Beckley Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$7.35
+0.01 (+0.14%)

Atai Beckley Inc. operates as a clinical-stage biopharmaceutical firm dedicated to the discovery, advancement, and commercialization of innovative therapeutic solutions for a variety of mental health conditions. The company's operations extend across the United States, Germany, and Canada. Its development pipeline features several key compounds: BPL-003: An intranasally administered formulation of…

Market Cap: $2.72Bwww.ataibeckley.com

Price

No data yet.

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Revenue

$1.70M
$-5.0K$6.62M$13.25M$19.88M
Mar 2020Jun 2026

Analyst Estimates

FY2025
$-0.62
$-0.64$-0.58
7 analysts
FY2026
$-0.43
$-0.71$-0.31
9 analysts
FY2027
$-0.45
$-0.60$-0.23
8 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Srinivas G. Rao
Sector
Healthcare
Industry
Biotechnology
Employees
99
Beta
1.55
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
3.46
www.ataibeckley.com